Clinical Trial Update: TRAC Locus-inserted CD19-targeting STAR-T Cell Therapy in r/r B-NHL [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for TRAC locus-inserted CD19-targeting STAR-T cell therapy in relapsed/refractory B-cell non-Hodgkin lymphoma (Phase 1/Phase 2).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Non-hodgkin Lymphoma
• Non-hodgkin Lymphoma

Drugs mentioned

• TRAC locus-inserted CD19-targeting STAR-T cell therapy

Snippet

Sponsor: Chinese PLA General Hospital | Conditions: Non-hodgkin Lymphoma,B Cell | Phase 1, Phase 2 | Status: UNKNOWN